MicroRNA expression signatures associated with metastatic progression in papillary thyroid carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Papillary thyroid cancer (PTC) can metastasize, leading to poorer patient outcomes.
• Understanding the molecular differences between primary and metastatic tumors is crucial for developing targeted therapies.

Purpose of the Study:

• To compare microRNA (miRNA) expression profiles between primary PTC tumors and matched metastatic lesions.
• To identify specific miRNAs associated with tumor metastasis in fatal PTC cases.

Main Methods:

• Analysis of miRNA expression in primary and metastatic tumor samples from eight PTC patients who died from disease progression.
• Utilized quantitative real-time PCR for 64 preselected miRNAs, with normalization and differential expression analysis.
• Employed univariate and multivariate statistical methods, including the Benjamini-Hochberg false discovery rate (FDR) for adjustment.

Main Results:

• Five miRNAs (let-7e-5p, miR-10b-5p, miR-30e-3p, miR-423-5p, miR-483-3p) were differentially expressed in metastatic lesions compared to primary tumors.
• Following multivariate analysis, miR-10b-5p and miR-30e-3p were confirmed as independently overexpressed in metastatic tissues.

Conclusions:

• This research highlights distinct miRNA expression patterns in metastatic versus primary PTC tumors in fatal cases.
• The identified overexpressed miRNAs (miR-10b-5p, miR-30e-3p) are implicated in regulating cell migration, invasion, and apoptosis, suggesting their potential role in PTC metastasis.